SNDX

Conviction 25HealthcareScan · Thu, Sep 24, 2026

Syndax Pharmaceuticals Inc (SNDX) closed at $17.99 (+1.98%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 41, RS Rating 72, -28.5% from its 52-week high, -15.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SNDX$17.99+1.98%

ResistanceSupportVol 14Insider sell

Vol MA14 1.98M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Syndax Pharmaceuticals IncPHARMACEUTICAL PREPARATIONSwww.syndax.com ↗

Price17.99

Change+1.98%

Gap-0.28%

Rel volume1.60×

Avg volume1.81M

Avg $ vol33.72M

SMA 2018.94

SMA 5019.77

SMA 20020.94

Price vs 50-9.00%

Price vs 200-14.08%

MA stackbearish

50/200 cross—

Supertrenddown · 19.98

RSI (14)41

MACD hist-0.07

MACD cross—

Stoch %K / %D23 / 21

ADX (14)31

+DI / −DI12 / 29

RSI divergence—

MACD divergence—

ATR %4.70%

ADR %3.98%

52w high25.15

52w low13.11

From 52w high-28.47%

Above 52w low+37.22%

New 52w highNo

SqueezeOff

Bollinger width24.00%

%B0.29

Donchian pos23.02%

Donchian high21.00

Donchian low17.09

AVWAP (52w high)20.55

vs AVWAP high-12.47%

AVWAP (52w low)19.88

vs AVWAP low-9.53%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d1.60×

Avg vol (14d)1.98M

Avg vol (20d)1.81M

Avg $ vol (20d)33.72M

Market cap1.61B

RS Rating72 / 99

RS 3m (vs SPY)-13.68%

RS 6m (vs SPY)-42.48%

RS line new highNo

Trend template3/8

Technical rank21.0

1 week+1.75%

1 month-9.69%

3 months-9.19%

6 months-25.66%

1 year+21.14%

YTD-15.54%

P/E-5.63

P/B106.39

P/S9.32

P/FCF-4.97

EPS-3.29

Div yield—

ROE—

ROA-40.56%

Debt/Eq23.18

Current6.77

EV/EBITDA—

Gross margin—

Net margin-165.60%

Rev growth627.84%

EPS growth10.46%

Price target37.33

Target upside107.50%

Analyst ratingBuy

Institutional129.15%

Ent. value1.62B

Revenue72.79M

Net income-49.36M

Gross profit—

Free cash flow-323.17M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.61M

Employees298

ListedThu, Mar 3, 2016

Free float83.06M

Float %93.5%

Short interest21.68M

Days to cover19.6d

Short volume62.5%

Squeeze score89 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.55 vs −$0.45

Last surprise-22.2% miss

Setup gradeD

Conviction25 / 100

Pattern quality—

Tech rank21.0 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance20.96

Support17.23

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNDX

All disclosures →

No recent disclosed trades by Congress in SNDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNDX · open-market 3 sells

Insider	Side	Shares	Value	Traded	Filed
Metzger Michael A Chief Executive Officer · Common Stock · 2026-07-08	Exercise	32.38K	$207K	2026-07-08	2026-07-09
Metzger Michael A Chief Executive Officer · Common Stock · 2026-07-08	Sell	32.38K	$785K	2026-07-08	2026-07-09
Metzger Michael A Chief Executive Officer · Stock Option (Right to buy) · 2026-07-08	Exercise	32.38K	—	2026-07-08	2026-07-09
Goldan Keith A. Chief Financial Officer · Common Stock · 2026-06-01	Sell	1.18K	$22K	2026-06-01	2026-06-02
Metzger Michael A Chief Executive Officer · Common Stock · 2026-06-01	Sell	6.85K	$130K	2026-06-01	2026-06-02

SEC filings

EDGAR filings in SNDX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.